Business · 14/04/2003

FDA Amends Notice on Estrogen-Androgen Combination Drugs for Menopause Treatment

The FDA is reclassifying certain estrogen-androgen combination drugs due to a lack of substantial evidence supporting their effectiveness in treating moderate to severe menopause symptoms in patients not responding to estrogen alone, and is offering a hearing opportunity for those affected.